Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BIOLOTCMKTS:LENSFOTCMKTS:MAGAANASDAQ:STSS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBIOLBIOLASE$0.01-20.0%$0.01$0.02▼$1.94$267K0.672.58 million shs106,171 shsLENSFPresbia$0.02$0.02$0.00▼$0.19$257K5.915,650 shsN/AMAGAAMagna-Lab$0.06+33.1%$0.06$0.11▼$2.00$72K7.513,117 shs200 shsSTSSSharps Technology$4.05+2.8%$14.16$3.36▼$5,446.32$219K2.14177,788 shs60,523 shsInvesting Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBIOLBIOLASE-20.00%-20.79%-32.20%-8.05%-95.83%LENSFPresbia0.00%0.00%0.00%0.00%0.00%MAGAAMagna-Lab+32.93%-31.29%+21.14%-10.21%-93.42%STSSSharps Technology+2.79%-11.38%-53.77%-96.21%+404,999,900.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBIOLBIOLASE0.9191 of 5 stars3.50.00.00.00.60.00.0LENSFPresbiaN/AN/AN/AN/AN/AN/AN/AN/AMAGAAMagna-LabN/AN/AN/AN/AN/AN/AN/AN/ASTSSSharps Technology0.9959 of 5 stars0.04.00.00.02.01.70.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBIOLBIOLASE 3.00Buy$1.2014,900.00% UpsideLENSFPresbia 0.00N/AN/AN/AMAGAAMagna-Lab 0.00N/AN/AN/ASTSSSharps Technology 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBIOLBIOLASE$48.83M0.01N/AN/A($0.07) per share-0.11LENSFPresbiaN/AN/AN/AN/AN/AN/AMAGAAMagna-LabN/AN/AN/AN/A($1.52) per shareN/ASTSSSharps TechnologyN/AN/AN/AN/A$11.42 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBIOLBIOLASE-$20.63M-$14.94N/A∞N/A-41.65%-1,782.73%-55.31%8/6/2025 (Estimated)LENSFPresbiaN/AN/A0.00∞N/AN/AN/AN/AN/AMAGAAMagna-Lab-$130K$0.180.34∞N/AN/A-12.32%42,399.99%N/ASTSSSharps Technology-$9.84M-$1,881.93N/A∞N/AN/A-110.40%-73.60%N/ALatest MAGAA, BIOL, LENSF, and STSS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/15/2025Q1 2025STSSSharps TechnologyN/A$38.62N/A$38.62N/AN/A3/27/2025Q4 2024STSSSharps Technology-$198.00-$861.00-$663.00-$2.87$14.60 millionN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBIOLBIOLASEN/AN/AN/AN/AN/ALENSFPresbiaN/AN/AN/AN/AN/AMAGAAMagna-LabN/AN/AN/AN/AN/ASTSSSharps TechnologyN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBIOLBIOLASEN/A0.710.36LENSFPresbiaN/AN/AN/AMAGAAMagna-LabN/AN/AN/ASTSSSharps TechnologyN/A1.010.57Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBIOLBIOLASE8.79%LENSFPresbiaN/AMAGAAMagna-LabN/ASTSSSharps Technology17.17%Insider OwnershipCompanyInsider OwnershipBIOLBIOLASE0.27%LENSFPresbia74.20%MAGAAMagna-Lab15.30%STSSSharps Technology1.46%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBIOLBIOLASE16033.41 million33.32 millionNot OptionableLENSFPresbia2017.12 millionN/ANot OptionableMAGAAMagna-Lab201.18 millionN/ANot OptionableSTSSSharps Technology354,0005.42 millionNot OptionableMAGAA, BIOL, LENSF, and STSS HeadlinesRecent News About These CompaniesSharps Technology Regains Nasdaq ComplianceMay 22 at 11:22 AM | tipranks.comSharps Technology Regains Compliance with Nasdaq Minimum Bid Price Listing RuleMay 22 at 7:00 AM | globenewswire.comSharps Technology, Inc. CEO Robert Hayes to Present at Aegis Capital Corp. 2025 Virtual Conference on May 22May 21 at 3:41 PM | quiverquant.comSharps Technology to Present at the Aegis Capital Corp. 2025 Virtual Conference on May 22ndMay 21 at 3:00 PM | globenewswire.comSharps Technology Inc.May 17, 2025 | barrons.comSharps Technology Receives ~$100K Initial Purchase Order from Hungarian Vaccine Provider for SecureGard™ SyringesMay 7, 2025 | finance.yahoo.comSharps Technology Secures $100,000 Order for SecureGard SyringesMay 6, 2025 | tipranks.comSharps Technology To Begin Generating Revenue, Stock Shoots Up On $400K OrderApril 30, 2025 | msn.comSharps Technology Secures $400K Initial Purchase Order from U.S. Leader in IV Flushing Solutions as Part of $50 Million SoloGard Supply AgreementApril 30, 2025 | finance.yahoo.comSharps Technology, Inc. Announces 1-for-300 Reverse Stock Split to Comply with Nasdaq Listing RequirementsApril 26, 2025 | nasdaq.comSharps Technology Inc trading halted, news pendingApril 26, 2025 | markets.businessinsider.comSharps Technology to effect 1-for-300 reverse stock splitApril 25, 2025 | finance.yahoo.comSharps Technology Urges Approval for Reverse Stock SplitMarch 20, 2025 | tipranks.comSharps Technology, Inc. Reminds Shareholders to Vote Before Important Shareholder Meeting on March 28, 2025March 20, 2025 | globenewswire.com10 Most Active US Stocks To Buy According to Hedge FundsMarch 13, 2025 | insidermonkey.comSharps Technology issues letter to shareholdersMarch 6, 2025 | markets.businessinsider.comSharps Technology's CEO Issues Corporate Update Highlighting Agreements for SecureGard and SoloGard and Revenue Developments from Manufacturing Operations in HungaryMarch 6, 2025 | globenewswire.comWhat’s Causing Sharps Technology Inc (STSS) Stock’s -94.83% Drop Over the Last Six Months?February 4, 2025 | bovnews.comSharps Technology, Inc. Closes $20 Million Public Offering with Aegis Capital Corp. as Sole Book-Running ManagerJanuary 29, 2025 | quiverquant.comTRIB, SLXN, STSS: Why Retail Chatter On 3 Nano-Cap Healthcare Stocks Exploded Over 6000%January 29, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeMAGAA, BIOL, LENSF, and STSS Company DescriptionsBIOLASE NASDAQ:BIOL$0.0080 0.00 (-20.00%) As of 05/22/2025BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, hygiene, temporary pain relief, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces; and sells teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.Presbia OTCMKTS:LENSF$0.02 0.00 (0.00%) As of 10/21/2022Presbia PLC, an ophthalmic device company, develops and markets optical lens implants for treating presbyopia. The company provides the refractive lens for patient surgeries, as well as accessories for procedures. It primarily operates in the United States, South Korea, Australia, Italy, the Netherlands, Ireland, Canada, and Germany. The company was founded in 2014 and is headquartered in Dublin, Ireland.Magna-Lab OTCMKTS:MAGAA$0.06 +0.02 (+33.08%) As of 05/22/2025Magna-Lab Inc. does not have significant operations. It intends to identify and merge with an operating company. Previously, the company was engaged in the research, development, and commercialization of disposable medical devices to enhance the effectiveness of magnetic resonance imaging in detection and diagnosis of heart disease. The company was founded in 1991 and is based in Plainview, New York. Magna-Lab Inc. is a subsidiary of Magna Acquisition LLC.Sharps Technology NASDAQ:STSS$4.05 +0.11 (+2.79%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$3.99 -0.06 (-1.48%) As of 05/23/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Sharps Technology, Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc. was incorporated in 2017 and is based in Melville, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/19 - 05/23 Turbulence for Joby Shares: What's Behind the Recent Dip? Pfizer's 7.5% Dividend: Income Haven or House of Cards? TJX Stock Price Stumble Is Your Chance to Pick Up a Bargain Advance Auto Parts Jumps on Surprise Earnings Beat Costco Stock at $1K: Dominance or Danger Zone? Williams-Sonoma: A Fundamentally Good Buy On Sale Now Snowflake Breaks Out! Can It Drift Higher in 2025 and Beyond? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
